Hc Biopharma Inc.
Clinical trials sponsored by Hc Biopharma Inc., explained in plain language.
-
New drug combo enters human testing for Tough-to-Treat lung cancers
Disease control Recruiting nowThis is an early-stage trial testing a new drug called HC010 when given alongside standard chemotherapy to people with advanced lung cancer. The main goals are to find a safe and tolerable dose and to get a first look at whether the combination might help control the cancer. The …
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug combo enters human testing
Disease control Recruiting nowThis early-stage study aims to find a safe and tolerable dose of an investigational drug called HC010 when given alongside standard chemotherapy to people with advanced solid tumors, particularly gastrointestinal cancers. Researchers will closely monitor side effects and how the …
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New drug trial targets advanced lung cancer in First-Line treatment
Disease control Recruiting nowThis study is testing an experimental drug called HC010 for people with advanced non-small cell lung cancer who have not yet received treatment for their advanced disease. The trial will enroll 50 adults with specific cancer characteristics (PD-L1 positive) to see how well HC010 …
Phase: PHASE2 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC